HIV Type 1 B′/C Recombinant (CRF07_BC) in Virologic Noncontrollers Elicits Neutralizing Antibodies Against Heterologous But Not Autologous Viruses

Abstract

Get full access to this article

View all access options for this article.

References

, Jia

, Ma

et al. The changing face of HIV in China. Nature, 2008; 455:609–611.

Liu

, Xing

, He

et al. Dynamic analysis of genetic diversity of gag and env regions of HIV-1 CRF07_BC recombinant in intravenous drug users in Xinjiang Uvghur Autonomous Region, China. Arch Virol, 2008; 153:1233–1240.

, Guo

, Yuan

et al. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China. Retrovirology, 2009; 6:45.

Deeks

, Schweighardt

, Wrin

et al. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: Evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol, 2006; 80:6155–6164.

Mandy

, Nicholson

, McDougal

. Guidelines for performing single-platform absolute CD4 + T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep, 2003; 52:1–13.

Montefiori

. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol, 2005; Chapter 12:Unit.

Albert

, Abrahamsson

, Nagy

et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS, 1990; 4:107–112.

Wei

, Decker

, Wang

et al. Antibody neutralization and escape by HIV-1. Nature, 2003; 422:307–312.

Koelsch

, Smith

, Little

et al. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS, 2003; 17:F11–F16.

10.

Smith

, Wong

, Hightower

et al. Incidence of HIV superinfection following primary infection. JAMA, 2004; 292:1177–1178.

11.

Gonzales

, Delwart

, Rhee

et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J Infect Dis, 2003; 188:397–405.